Astec Lifesciences (NSE:ASTEC) Other Current Assets: ₹441 Mil (As of Mar. 2026)


NSE:ASTEC Astec Lifesciences Ltd NSE:ASTEC
79 GF Score
Price ₹689.20
GF Value ₹991.55
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Astec Lifesciences Other Current Assets?

Astec Lifesciences NSE:ASTEC +0.37% 79 Other Current Assets is ₹441 Mil as of Mar. 2026. GuruFocus rates NSE:ASTEC with a GF Score™ of 79/100 and a GF Value™ of ₹991.55 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Astec Lifesciences's other current assets for the quarter that ended in Mar. 2026 was ₹441 Mil.

Astec Lifesciences's quarterly other current assets declined from Sep. 2025 (₹372 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹441Mil).

Astec Lifesciences's annual other current assets declined from Mar. 2024 (₹314 Mil) to Mar. 2025 (₹302 Mil) increased from Mar. 2025 (₹302 Mil) to Mar. 2026 (₹441 Mil).


Astec Lifesciences Other Current Assets Related Terms


Astec Lifesciences Other Current Assets Historical Data

* Premium members only.

The historical data trend for Astec Lifesciences's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astec Lifesciences Other Current Assets Chart

Astec Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 494.25 482.12 314.13 301.92 441.09

Astec Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 301.92 0.00 371.91 0.00 441.09
NSE:ASTEC
79GF Score
Astec Lifesciences Ltd NSE:ASTEC
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astec Lifesciences Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of ₹441 Mil mean?
Astec Lifesciences (NSE:ASTEC) has a Other Current Assets of ₹441 Mil as of Mar. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Astec Lifesciences.
Is Astec Lifesciences' Other Current Assets too high?
Astec Lifesciences' current Other Current Assets is ₹441 Mil. Overall, Astec Lifesciences has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Other Current Assets compare to CTVA and CF?
Astec Lifesciences' Other Current Assets of ₹441 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for an Agriculture company?
A good Other Current Assets depends on the Agriculture industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Astec Lifesciences. Astec Lifesciences's current Other Current Assets is ₹441 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹991.55, compared to a current price of ₹689.20 — trading 30.5% below its estimated fair value. The current Other Current Assets is ₹441 Mil. Astec Lifesciences' overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current Other Current Assets is ₹441 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹689.20 is trading 30.5% below its estimated GF Value™ of ₹991.55. GuruFocus considers Astec Lifesciences to be Significantly Undervalued.

Key valuation signals for NSE:ASTEC:

  • Other Current Assets: ₹441 Mil
  • GF Value™: ₹991.55 vs. price of ₹689.20 (30.5% below fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Astec Lifesciences Business Description

Other Exchanges 533138:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
79GF Score

Get the complete analysis for NSE:ASTEC

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹689.20
Price
₹991.55
GF Value